-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Atossa Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2012 to 2023.
- Atossa Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $352K, a 78% decline year-over-year.
- Atossa Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $2.21M, a 65.3% decline year-over-year.
- Atossa Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $4.62M, a 31.9% decline from 2022.
- Atossa Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $6.79M, a 28.9% increase from 2021.
- Atossa Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.27M, a 74.5% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)